Attached files
| file | filename |
|---|---|
| EX-10.3.1 - EXHIBIT 10.3.1 - ANGIODYNAMICS INC | ex1031stockoptionagreement.htm |
| EX-10.1.7 - EXHIBIT 10.1.7 - ANGIODYNAMICS INC | ex1017totalshareholderretu.htm |
| 10-K - 10-K - ANGIODYNAMICS INC | ango-053118x10k.htm |
| EX-32.2 - EXHIBIT 32.2 - ANGIODYNAMICS INC | ex3225311810-k.htm |
| EX-32.1 - EXHIBIT 32.1 - ANGIODYNAMICS INC | ex3215311810-k.htm |
| EX-31.2 - EXHIBIT 31.2 - ANGIODYNAMICS INC | ex3125311810-k.htm |
| EX-31.1 - EXHIBIT 31.1 - ANGIODYNAMICS INC | ex3115311810-k.htm |
| EX-23 - EXHIBIT 23 - ANGIODYNAMICS INC | ex23angio2018consentofdelo.htm |
| EX-21 - EXHIBIT 21 - ANGIODYNAMICS INC | ex2153118.htm |
| EX-10.4.5 - EXHIBIT 10.4.5 - ANGIODYNAMICS INC | ex1045performanceunitaward.htm |
| EX-10.1.1 - EXHIBIT 10.1.1 - ANGIODYNAMICS INC | ex1011amendmentno1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S‑3 (No. 333-190642) of AngioDynamics, Inc. of our report dated August 1, 2016 relating to the consolidated financial statements and financial statement schedule, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
July 23, 2018